DIBIASE MARY (Chief Operating Officer) sold 5.0% of their position (15.41K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $13.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2024ACC: 0001628280-24-010278
Officer· Chief Operating Officer
Since Sep 2021
-15.41K
Net shares
Net seller
$13.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.41K
Price / share
$0.88
Trade value
$13.59K
% of position
5.0%
3/11/2024
307.16K→291.75K
Total
Net shares
−15.41K
Net value
-$13.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | S · Sale | −15.41K | $0.88 | $13.59K | 5.0% | 307.16K | 291.75K |
| Total | −15.41K | -$13.59K | ||||||
Derivative Transactions0
No derivative transactions reported